Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC and PRP for Knee Osteoarthritis
NCT02958267Phase 2Completed
- Sponsor
- OhioHealth
- Start
- Dec 2016
- Primary completion
- Aug 2018
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous bone marrow cell concentrate and autologous platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by OhioHealth. Primary endpoint: Knee Injury and Osteoarthritis Outcome at 12 months. Started Dec 2016; status: completed.
02
Drugs
autologous bone marrow cell concentrateautologous platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02958267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958267.